Efficacy and safety of cannabinoids in the treatment of spasticity in multiple sclerosis: A systematic review of randomized clinical trials. Hamm-Buiar L, Gorski D, Kagueiama M H, Wiens A Br J Clin Pharmacol. 2026 Aug 02. PMID: 42543771. Abstract CommentRecommendBookmarkWatch